Modification of tumor suppressor gene expression and induction of apoptosis in non-small cell lung cancer (NSCLC) with an adenovirus vector expressing wildtype p53 and cisplatin

Hum Gene Ther. 1996 May 20;7(8):1013-30. doi: 10.1089/hum.1996.7.8-1013.
No abstract available

MeSH terms

  • Adenoviridae / genetics*
  • Antineoplastic Agents / therapeutic use*
  • Apoptosis / genetics*
  • Carcinoma, Non-Small-Cell Lung / drug therapy
  • Carcinoma, Non-Small-Cell Lung / pathology
  • Carcinoma, Non-Small-Cell Lung / therapy*
  • Cisplatin / therapeutic use*
  • Clinical Protocols
  • Combined Modality Therapy
  • Genes, p53*
  • Genetic Vectors
  • Humans
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / pathology
  • Lung Neoplasms / therapy*
  • Patient Selection

Substances

  • Antineoplastic Agents
  • Cisplatin